Global

Knowledge Center

Corporate Blog

Featured Video


CSL CEO Paul Perreault discusses company's patient advocacy role.
Click to view
CSL Behring is a biotherapies company committed to saving lives and improving the lives of people with rare and serious diseases worldwide.

We publish magazines, brochures, newsletters and policy papers that address healthcare issues associated with our biotherapies. These publications include our Key Issues Dialogue series.

Publications

Key Issues Dialogue is a magazine series presenting discussions among thought leaders about important and emerging issues that are vitally important to people with diseases treated by CSL Behring biotherapies. These dialogues offer an exchange of valuable information and viewpoints about the latest medical and research advances.

Resources

Useful Links provides a link to and a synopsis of other recognized and respected Web sites, including patient and healthcare organizations.

Browse Audio & Video, items of interest to CSL Behring audiences.

Share
LinkedIn Twitter Facebook Google+